Vital Images signs Chindex as reseller

Article

Carestream Health ships DRX-1Aposense imaging agent detects early cell death

Vital Images signs Chindex as reseller

Chindex International will sell advanced visualization software from Vital Images as part of its China portfolio. Chindex provides healthcare services and medical products to China-based hospitals and clinics, including more than 750 Level 1 trauma centers. Vital Images' software processes CT and MR data into 2D and volumetric images.

Carestream Health ships DRX-1

Wireless, cassette-size digital radiography detectors have begun shipping from Carestream Health as the company fills orders placed several months ago from countries around the world for its new DRX-1. The wireless detector is designed for radiographic exams, including those in general radiology, trauma, and orthopedics. The DRX-1 system minimizes installation costs by integrating this detector with a console, thereby requiring no modifications to existing analog equipment.

Aposense imaging agent detects early cell death

Whether radiation therapy is having the desired effect on brain tumors may be seen with the use of a PET imaging agent, according to data presented last week at the SNM meeting. The PET tracer, F-18 ML-10, developed by Aposense, targets apoptosis (programmed cell death) for molecular imaging and therapy. Eight tumors in seven patients demonstrated baseline images of pretreatment apoptosis, with ML-10 uptake increasing over time within the tumors compared with the nontarget tissue and blood. Following treatment, the signal in irradiated tumors increased nearly twofold, indicating a marked increase in the accumulation of ML-10 in tumors compared with other tissues.

Recent Videos
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
Related Content
© 2025 MJH Life Sciences

All rights reserved.